T-cell Lymphoma of the prostate: Remission with Doxorubicin-Based Combination Chemotherapy.
- Author:
Taek Won KANG
;
Bong Ryoul OH
;
Soo Bang RYU
;
Yang Il PARK
;
Hyeung Joon KIM
- Publication Type:Original Article
- Keywords:
Prostate;
Tumor;
Lymphoma;
Chemotherapy
- MeSH:
Bees;
Consensus;
Drug Therapy;
Drug Therapy, Combination*;
Humans;
Lymphoma;
Lymphoma, T-Cell*;
Prognosis;
Prostate*;
Prostatectomy;
Radiotherapy;
T-Lymphocytes*;
Urinary Bladder Neck Obstruction
- From:Korean Journal of Urology
2001;42(1):120-123
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Lymphoma of the prostate is exceedingly rare. Much more common than primary lymphoma of the prostate id secondary involvement of malignant lymphomas originating at other sites. A variety of treatments have bee n used, including prostatectomy, radiotherapy or combinations of chemotherapy and radiotherapy. Generally, the prognosis is very poor, and there is currently no consensus regarding treatment. We report on a patient with T-cell lymphoma who presented with symptoms of bladder neck obstruction. The patient has been asymptomatic and under complete remission after completion of doxorubicin-based chemotherapy for 2 cycles.
